Aica Ribonucleotide is a peptide whose technical name is 5- Aminoimidazole-4-carboxamide ribonucleotide. It is available for purchase for the purposes of scientific study on animal test subjects under several different names such as !"# AI$AR and Acadesine. It is presented in white powder form and contains a molecular wei%ht of &&'.()))*(. Aica Ribonucleotide is also referred to as Aicar online and in most research communities. +ow Aica Ribonucleotide ,or-s Accordin% to scientific study on animal test subjects Aica Ribonucleotide.s mechanics allow for the acceleration of metabolic processes within animal test subjects. /hese accelerations manifest themselves in the followin% methods0 Increased glucose uptake 1 Aica Ribonucleotide has been determined to boost %lyco%en synthesis which in turn leads to an increased synthesis of the proteins that are responsible for s-eletal muscle buildin% and repair. Decreased Insulin Resistance 1 /he peptide contains the ability to be able to boc- the receptors that would normally inhibit the inta-e of insulin2 the peptide that is responsible for the causation of cells in the liver s-eletal muscles and fat tissue to absorb %lucose from the blood. /his bloc-in% of such inhibitions allows for an elevated ta-e of %lucose inta-e which in turn allows for a more efficient ener%y conversion process. /his in turn allows for an elevated rate of metabolic processes relatin% to the muscular and s-eletal structures found in animal test subjects. More Efficient Regulation of Energy 1 3ecause of Aica Ribocluneotide.s ability to accelerate the synthesis of %lyco%en scientific study on animal test subjects has determined that the peptide can control the distribution and usage of energy in a more efficient manner. /his increased efficiency has been tied to several benefits as they relate to several functions re%ardin% an animal test subjects. body includin% a boost of endurance and an increased facility to burn fat. Aica Ribonucleotide.s Relationship with $ardiac Ischemic Injuries ,hile scientific research conducted on animal test subjects has determined that Aica Ribonucleotide.s ability to expedite the subjects. metabolic processes the peptide.s efficient nature has caused study to especially hone in on its potential effects relatin% to cardiac ischemic injuries. Click here to buy Aicar in our store At its base point a cardiac ischemic injury is classified as an affliction whose cause is tied to a restriction of blood supply to tissues. /his in turn causes an insufficient amount of %lucose and oxy%en to be delivered in order to maintain a re%ulated amount of cellular functionality within the heart muscle. ,ithout proper cellular functionality the heart starts to fail. #rimarily cardiac ischemic injuries are directly brou%ht on by a condition -nown as an%ina pectoris. /his condition routinely referred to as an%ina is characterized by an insufficient amount of blood flow to the heart. /his insufficient blood flow translates into an insufficient amount of oxy%en and %lucose bein% provided to heart muscle cells which in turn causes the heart to malfunction. +owever an%ina pectoris can sometimes be asymptomatic in its presentation. /his condition could lead to a host of serious heart-related elements up to and includin% cardiac arrest. /he scientific study based on animal test subjects has led to the theory that Aica Ribonucleotide.s ability to improve the metabolic processes within a subjects. body would lessen the restriction of blood flow to the heart muscle creatin% a more consistent sense of re%ulation in the process. /his would theoretically enable a partially reduced ris- of an%ina pectoris from occurrin% and by extension a reduced ris- of heart failure. Additional theories based on such scientific study on animal test subjects lin- the peptide as a potential ally in re%ards to treatin% a heart attac- that was caused by a cardiac ischemic episode. /he reason for this theory also ties to Aica Ribonucleotide.s ability to lessen the restriction of blood flow to the heart as an increase in blood flow 1 and subse4uently and increase in %lucose and oxy%en %ettin% to cardiac cells 1 would aid in stabilizin% the heart as it recovers from an ischemic episode. Other Notes on Aica Ribonucleotides Functionality /here are two thin%s that should be noted in relation to Aica Ribonucleotide.s usa%e and functionality. /he first is that scientific study on animal test subjects has determined that a few side effects have been lin-ed to the peptide includin% some serious side effects lin-ed to the heart muscle. /he more serious side effects include0 Development of heart valve defects Pulmonary hypertension Abnormal growth of heart tissue 5econdly it should be noted that Aica Ribonucleotide is currently in the research phase. Any study or research based on the peptide should be rele%ated to animal test subjects and within the strict confines of a controlled environment such as a medical research facility or a laboratory.